
The notion of tailor-made drugs, which are customised to an individual patient’s needs, has seen remarkable progress of late. This …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment

